Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Tracon Pharmaceuticals, Inc. (TCON)
Sector: Healthcare; Industry: Biotechnology

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). The company also develops TRC102, a small molecule that is in Phase II clinical trial for mesothelioma, Phase I clinical trial for solid tumors and lung cancer, and Phase I/II clinical trial for solid tumors and lymphomas; and TRC253, a small molecule high affinity competitive inhibitor of wild type androgen receptor (AR) and multiple AR mutant receptors that is in Phase I/II clinical trial for the treatment prostate cancer. The company has license agreements with Ambrx, Inc.; Santen Pharmaceutical Co. Ltd.; Roswell Park Cancer Institute and Health Research Inc.; Case Western Cancer Center; and Lonza Sales AG, as well as a cooperative research and development agreement with National Cancer Institute. TRACON Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-01-24 Opaleye Management Inc. 10%-Owner Buy 52,363 $2.15 $112,414 No
2022-01-20 Opaleye Management Inc. 10%-Owner Buy 45,000 $2.25 $101,032 No
2021-12-29 Opaleye Management Inc. 10%-Owner Buy 52,325 $2.51 $131,362 No
2021-12-15 Opaleye Management Inc. 10%-Owner Buy 21,964 $2.43 $53,287 No
2021-12-14 Opaleye Management Inc. 10%-Owner Buy 57,204 $2.56 $146,498 No
2021-12-06 Opaleye Management Inc. 10%-Owner Buy 112,007 $2.29 $256,385 No
2021-12-02 Opaleye Management Inc. 10%-Owner Buy 60,500 $2.39 $144,820 No
2021-11-19 THEUER CHARLES President and CEO Buy 4,181 $2.83 $11,831 No
2021-11-05 THEUER CHARLES President and CEO Buy 4,000 $3.41 $13,655 No
2021-08-13 Brown Scott B. Chief Financial Officer Buy 1,000 $3.69 $3,695 No
2021-07-26 LARUE WILLIAM R Director Buy 6,545 $3.82 $25,002 No
2021-03-08 Brown Scott B. Chief Financial Officer Buy 1,000 $8.30 $8,296 No
2021-01-27 THEUER CHARLES President and CEO Buy 11,000 $8.98 $98,771 No
2020-12-30 Ikarian Capital, LLC Member of 10% Group Buy 520,291 $9.61 $4,999,997 No
2020-12-29 WIGGINS MARK C Chief Business Officer Buy 1,000 $10.57 $10,570 No
2020-12-22 Opaleye Management Inc. 10%-Owner Buy 496,277 $8.06 $3,999,993 No
2020-11-11 Ikarian Capital, LLC Member of 10% Group Buy 34,000 $5.10 $173,269 No
2020-10-21 Opaleye Management Inc. 10%-Owner Buy 8,656 $4.40 $38,060 No
2020-10-21 THEUER CHARLES President and CEO Buy 2,000 $4.38 $8,769 No
2020-09-24 Opaleye Management Inc. 10%-Owner Buy 78,734 $4.73 $372,095 No
2020-09-23 THEUER CHARLES President and CEO Buy 5,000 $4.72 $23,599 No
2020-09-11 Ikarian Capital, LLC Member of 10% Group Buy 322,471 $3.28 $1,057,387 No
2020-09-11 Ikarian Capital, LLC Member of 10% Group Buy 322,471 $3.28 $1,057,387 No
2020-09-10 WIGGINS MARK C Chief Business Officer Buy 7,000 $4.14 $28,953 No
2020-09-09 Opaleye Management Inc. 10%-Owner Buy 56,558 $3.38 $190,902 No
2020-09-04 THEUER CHARLES President and CEO Buy 10,000 $2.58 $25,750 No
2020-09-02 Opaleye Management Inc. 10%-Owner Buy 159,800 $2.28 $363,825 No
2020-08-31 Opaleye Management Inc. 10%-Owner Buy 545,504 $1.74 $950,378 Yes
2020-08-21 THEUER CHARLES President and CEO Buy 5,325 $1.56 $8,307 No
2020-08-20 THEUER CHARLES President and CEO Buy 30,000 $1.58 $47,400 No

Insider Smart

Liberty Media Corp (LSXMA) - BERKSHIRE HATHAWAY INC, Buffett made a move and add 2M shares to their position. What a news after dumping Airlines.